Xcout IntelSign inSubscribe

ENCISION INC competitors & alternatives

ECIAMedical - Instruments & SuppliesBoulder, United States

The 12 closest competitors and alternatives to ENCISION INC among medical - instruments & supplies companies — ranked by similarity to what ENCISION INC actually does, not by market-cap band.

$562,747Market cap
22Employees
12Competitors listed

Subscribe to see ENCISION INC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About ENCISION INC

Encision Inc. (ECIA), established in 1991 and headquartered in Boulder, Colorado, operates as a medical device firm specializing in the development, manufacturing, and commercialization of proprietary surgical instruments for the U.S. market. The company's core offering revolves around its patented Active Electrode Monitoring (AEM) technology, featured in both surgical instruments and dedicated monitors. This innovative system significantly enhances patient safety and optimizes outcomes during laparoscopic surgical procedures. Encision's AEM instrument portfolio encompasses a diverse array of endo-mechanical tools, such as scissors, graspers, and dissectors, alongside specialized fixed-tip and suction-irrigation electrodes. Beyond these, the company supplies specialized handles designed for complex laparoscopic operations, characterized by their robust shafts and ergonomic designs. They also provide the AEM EndoShield 2 burn protection systems. Complementing these instruments, Encision markets its AEM monitor product line, essential for use in conjunction with its AEM instruments. Distribution of Encision's products occurs through a hybrid sales model, leveraging both direct company representatives and an established network of independent sales agents.

ENCISION INC at a glance

ENCISION INC is a medical - instruments & supplies company headquartered in Boulder, United States. It is publicly listed (ECIA) with a market capitalisation of $562,747. Xcout tracks 22 named people at ENCISION INC, including Robert H. Fries (Interim President, CEO & Director).

ENCISION INC leadership

  • Robert H. FriesInterim President, CEO & Director
  • Jason JohnsonVice President of Sales
  • Brandon ShepardVice President of Controller, Treasurer & Corporate Secretary
  • Vern D KornelsenCo-Founder and Director
  • David W. NewtonCo-Founder
  • Brandon H. ShepardExecutive Officer

16 more named people on record for ENCISION INC, with roles, board committees and tenure — see the full roster →

Top 12 ENCISION INC competitors

Ranked by semantic similarity — how close each company is to ENCISION INC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

AngioDynamics, Inc.ANGO · Medical - Instruments & SuppliesLatham, United States
63% matchPublic

Similar medical - instruments & supplies company

AngioDynamics, Inc. specializes in the development, manufacturing, and commercialization of a diverse array of medical, surgical, and diagnostic instruments. These products are utilized by healthcare professionals to address conditions such as peripheral vascular disease, facilitate vascular access, and support various oncology and surgical interventions, serving both domestic and international markets. The company's portfolio includes advanced ablation systems like NanoKnife, designed for the precise surgical removal of soft tissues, and Solero microwave and radiofrequency systems, effective in ablating solid cancerous or benign growths. Additionally, they provide BioSentry tract sealant systems, IsoLoc Endorectal Balloons, Alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. Their endovascular therapies segment encompasses solutions for thrombus management, atherectomy procedures, core peripheral products, and the treatment of venous insufficiency. Furthermore, AngioDynamics is a key supplier of vascular access devices, such as peripherally inserted central catheters (PICCs), midline catheters, implantable ports, and dialysis catheters, along with associated accessories. These are primarily employed for short-duration systemic drug delivery, including chemotherapy and antibiotics, marketed under a robust portfolio of brand names such as BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax. The company distributes its offerings directly to a specialized clientele, including interventional radiologists, cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses, while also leveraging established distributor networks. Founded in 1988, AngioDynamics maintains its corporate headquarters in Latham, New York.

Market cap$476.1M
Employees632
AngioDynamics, Inc. competitors & alternatives →
Bioventus Inc.BVS · HealthcareDurham, United States
64% matchPublic

Healthcare

Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company’s product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain, and TalisMann provides stimulation to the targeted peripheral nerve, as well as XCELL PRP System, a benchtop device that processes whole blood to produce high-yield PRP with a 10-minute single-spin cycle. It also offers precision bone resection for patients with degenerative spine conditions and spinal deformities, as well as enables precision ultrasonic neuro and general surgery to address brain tumors and pathologies of the liver and other organs; and bone graft substitutes, including various products that facilitate optimal bone fusion. In addition, the company provides neXus, an ultrasonic surgical system; BoneScalpel, a surgical solution enabling precise cuts in hard tissue; BoneScalpel Access, for bone removal with visualization; SonaStar system, a precise ablation and removal of soft tissue; SonaStar Elite handpiece and accessories; SonicOne, an ultrasonic cleansing and debridement system; Osteoamp, an allograft-derived bone graft for orthopedic, neurosurgical, and reconstructive bone grafting procedures; Signafuse bone graft; Purebone, a natural osteoconductive scaffold; and Reficio demineralized bone matrix. The company’s restorative therapies include minimally invasive fracture treatments and rehabilitation products. Its products also include Exogen, an ultrasound bone stimulation system. The company sells its products to healthcare institutions, physicians, patients, distributors and dealers. Bioventus Inc. was founded in 2011 and is headquartered in Durham, North Carolina.

Market cap$940.3M
Employees940
Bioventus Inc. competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of ENCISION INC and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for ENCISION INCand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →